 long-term treatment acromegal patient somatostatin analog result intern multicent acromegali studi group background clinic biochem effect long-term therapi somatostatin analog acromegal patient method patient medic center day week median week octreotid dosag micrograms/d median micrograms/d serum growth hormon insulin-lik growth factor igf-i concentr end studi correl respons treatment total daili dosag durat treatment result clinic respons rate irrespect dosag treatment durat serum growth hormon level patient igf-i level mean pretreat growth level micrograms/l micrograms/l growth hormon level micrograms/l patient pretreat igf-i level u/ml u/ml suppress u/ml patient degre growth hormon suppress treatment durat total octreotid dosag day patient pituitari tumor size side effect patient commonli transient loos alcohol stool pain inject site abdomin discomfort sever mild glucos toler unchang patient conclus octreotid effect treatment acromegali primari therapi surgeri and/or pituitari irradi